These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The evolution of gene therapy in X-linked severe combined immunodeficiency. Rans TS; England R Ann Allergy Asthma Immunol; 2009 May; 102(5):357-62; quiz 363-5, 402. PubMed ID: 19492655 [TBL] [Abstract][Full Text] [Related]
6. Regulators split on gene therapy as patient shows signs of cancer. Check E Nature; 2002 Oct; 419(6907):545-6. PubMed ID: 12374936 [No Abstract] [Full Text] [Related]
7. Medical research: Gene-therapy reboot. Cassiday L Nature; 2014 May; 509(7502):651-3. PubMed ID: 24877176 [No Abstract] [Full Text] [Related]
8. Translational research: the full cycle. Ledford H Nature; 2008 Jun; 453(7197):843-5. PubMed ID: 18548044 [No Abstract] [Full Text] [Related]
9. Looking into the safety of AAV vectors. Kay MA; Nakai H Nature; 2003 Jul; 424(6946):251. PubMed ID: 12867952 [No Abstract] [Full Text] [Related]
10. Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency. Strauss BE; Costanzi-Strauss E Braz J Med Biol Res; 2007 May; 40(5):601-13. PubMed ID: 17464421 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy. Second child in French trial is found to have leukemia. Marshall E Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981 [No Abstract] [Full Text] [Related]
12. Promoter competition for gene therapy of SCID-X1. Baum C; Schambach A Hum Gene Ther; 2011 Mar; 22(3):255-6. PubMed ID: 21401346 [No Abstract] [Full Text] [Related]
13. Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis. Knight S; Collins M; Takeuchi Y Curr Gene Ther; 2013 Jun; 13(3):211-27. PubMed ID: 23590635 [TBL] [Abstract][Full Text] [Related]
14. A tragic setback. Check E Nature; 2002 Nov; 420(6912):116-8. PubMed ID: 12432357 [No Abstract] [Full Text] [Related]
15. Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies. Mohanlal R; Qiu Y; Zheng M; Mirkou A; Sridharan K; Keir C Mol Diagn Ther; 2016 Dec; 20(6):591-602. PubMed ID: 27435702 [TBL] [Abstract][Full Text] [Related]
16. False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector. De Ravin SS; Gray JT; Throm RE; Spindler J; Kearney M; Wu X; Coffin JM; Hughes SH; Malderelli F; Sorrentino BP; Malech HL Mol Ther; 2014 Feb; 22(2):244-245. PubMed ID: 24487563 [No Abstract] [Full Text] [Related]
18. Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Thornhill SI; Schambach A; Howe SJ; Ulaganathan M; Grassman E; Williams D; Schiedlmeier B; Sebire NJ; Gaspar HB; Kinnon C; Baum C; Thrasher AJ Mol Ther; 2008 Mar; 16(3):590-8. PubMed ID: 18180772 [TBL] [Abstract][Full Text] [Related]
19. Curing genetic disease with gene therapy. Williams DA Trans Am Clin Climatol Assoc; 2014; 125():122-8; discussion 128-9. PubMed ID: 25125725 [TBL] [Abstract][Full Text] [Related]
20. Case of leukaemia associated with X-linked severe combined immunodeficiency gene therapy trial in London. Board of the European Society of Gene and Cell Therapy Hum Gene Ther; 2008 Jan; 19(1):3-4. PubMed ID: 18380015 [No Abstract] [Full Text] [Related] [Next] [New Search]